BIOMAT Database Logo BIOMAT Database Logo

Tricyclic antidepressant and monoamine oxidase inhibitor combination therapy. 1977

L B Ponto, and P J Perry, and B I Liskow, and H H Seaba

UI MeSH Term Description Entries
D008297 Male Males
D008996 Monoamine Oxidase Inhibitors A chemically heterogeneous group of drugs that have in common the ability to block oxidative deamination of naturally occurring monoamines. (From Gilman, et al., Goodman and Gilman's The Pharmacological Basis of Therapeutics, 8th ed, p414) MAO Inhibitor,MAO Inhibitors,Reversible Inhibitors of Monoamine Oxidase,Monoamine Oxidase Inhibitor,RIMA (Reversible Inhibitor of Monoamine Oxidase A),Reversible Inhibitor of Monoamine Oxidase,Inhibitor, MAO,Inhibitor, Monoamine Oxidase,Inhibitors, MAO,Inhibitors, Monoamine Oxidase
D011817 Rabbits A burrowing plant-eating mammal with hind limbs that are longer than its fore limbs. It belongs to the family Leporidae of the order Lagomorpha, and in contrast to hares, possesses 22 instead of 24 pairs of chromosomes. Belgian Hare,New Zealand Rabbit,New Zealand Rabbits,New Zealand White Rabbit,Rabbit,Rabbit, Domestic,Chinchilla Rabbits,NZW Rabbits,New Zealand White Rabbits,Oryctolagus cuniculus,Chinchilla Rabbit,Domestic Rabbit,Domestic Rabbits,Hare, Belgian,NZW Rabbit,Rabbit, Chinchilla,Rabbit, NZW,Rabbit, New Zealand,Rabbits, Chinchilla,Rabbits, Domestic,Rabbits, NZW,Rabbits, New Zealand,Zealand Rabbit, New,Zealand Rabbits, New,cuniculus, Oryctolagus
D004359 Drug Therapy, Combination Therapy with two or more separate preparations given for a combined effect. Combination Chemotherapy,Polychemotherapy,Chemotherapy, Combination,Combination Drug Therapy,Drug Polytherapy,Therapy, Combination Drug,Chemotherapies, Combination,Combination Chemotherapies,Combination Drug Therapies,Drug Polytherapies,Drug Therapies, Combination,Polychemotherapies,Polytherapies, Drug,Polytherapy, Drug,Therapies, Combination Drug
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D000929 Antidepressive Agents, Tricyclic Substances that contain a fused three-ring moiety and are used in the treatment of depression. These drugs block the uptake of norepinephrine and serotonin into axon terminals and may block some subtypes of serotonin, adrenergic, and histamine receptors. However, the mechanism of their antidepressant effects is not clear because the therapeutic effects usually take weeks to develop and may reflect compensatory changes in the central nervous system. Antidepressants, Tricyclic,Tricyclic Antidepressant,Tricyclic Antidepressant Drug,Tricyclic Antidepressive Agent,Tricyclic Antidepressive Agents,Antidepressant Drugs, Tricyclic,Agent, Tricyclic Antidepressive,Agents, Tricyclic Antidepressive,Antidepressant Drug, Tricyclic,Antidepressant, Tricyclic,Antidepressive Agent, Tricyclic,Drug, Tricyclic Antidepressant,Drugs, Tricyclic Antidepressant,Tricyclic Antidepressant Drugs,Tricyclic Antidepressants

Related Publications

L B Ponto, and P J Perry, and B I Liskow, and H H Seaba
Relative Effectiveness of Monoamine Oxidase Inhibitor and Tricyclic Antidepressant Combination Therapy for Treatment-Resistant Depression.
January 2019, Journal of clinical psychopharmacology,
L B Ponto, and P J Perry, and B I Liskow, and H H Seaba
Combination monoamine oxidase inhibitor/tricyclic antidepressants interaction.
August 1982, Lancet (London, England),
L B Ponto, and P J Perry, and B I Liskow, and H H Seaba
Monoamine oxidase inhibitors (MAOI) or reversible inhibitors of monoamine oxidase (RIMA)/tricyclic antidepressant (TCA) combination therapy.
June 1992, The Australian and New Zealand journal of psychiatry,
L B Ponto, and P J Perry, and B I Liskow, and H H Seaba
Adding a tricyclic antidepressant to a monoamine oxidase inhibitor.
June 1982, Journal of clinical psychopharmacology,
L B Ponto, and P J Perry, and B I Liskow, and H H Seaba
Toxicity by interaction of tricyclic antidepressant and monoamine oxidase inhibitor.
December 1972, California medicine,
L B Ponto, and P J Perry, and B I Liskow, and H H Seaba
Combined monoamine oxidase inhibitor-tricyclic antidepressant treatment: a pilot study.
November 1980, The American journal of psychiatry,
L B Ponto, and P J Perry, and B I Liskow, and H H Seaba
Treatment of tricyclic refractory depression with a monoamine oxidase inhibitor antidepressant.
January 1987, Psychopharmacology bulletin,
L B Ponto, and P J Perry, and B I Liskow, and H H Seaba
Combining tricyclic and monoamine oxidase inhibitor antidepressants.
July 1976, Archives of general psychiatry,
L B Ponto, and P J Perry, and B I Liskow, and H H Seaba
Psychiatry-important advances in clinical medicine: combined tricyclic and monoamine-oxidase inhibitor antidepressant treatment.
March 1983, The Western journal of medicine,
L B Ponto, and P J Perry, and B I Liskow, and H H Seaba
Relative effectiveness of tricyclic antidepressant versus monoamine oxidase inhibitor monotherapy for treatment-resistant depression.
May 2019, Journal of affective disorders,
Copied contents to your clipboard!